| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 09/05/2007 | CN100335468C Diaryl amidine compound, its production, medicinal composition and use |
| 09/05/2007 | CN100335427C Oxygen scavenger and boiler water treatment chemical |
| 09/04/2007 | US7265378 Light emitting diodes |
| 09/04/2007 | US7265246 7-Aminoakyl-2-arylcarbonylaminoindanes, e.g., 3-Fluorobiphenyl-4-carboxylic acid (R)-(6-((3-ethoxypropylamino)methyl)-2R-hydroxyindan-1-yl)amide; treatment of cognitive impairment associated with schizophrenia, Alzheimer's disease, and psychoses |
| 09/04/2007 | US7265220 Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 09/04/2007 | US7265213 Methodology of conjugating chelators to biomolecules |
| 09/04/2007 | US7265143 C-4 substituted retinoids |
| 09/04/2007 | US7265137 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 09/04/2007 | US7265136 Substituted stilbene compounds with vascular damaging activity |
| 09/04/2007 | US7265130 anti-obestic activity; Neuropeptide Y antagonist |
| 09/04/2007 | CA2258044C Muscarinic antagonists |
| 08/30/2007 | WO2007098356A1 Congeners of milnacipran as monoamine re-uptake |
| 08/30/2007 | WO2007098352A2 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors |
| 08/30/2007 | WO2007097403A1 Remedy or preventive for digestive ulcer |
| 08/30/2007 | WO2007096647A2 Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer |
| 08/30/2007 | WO2007096072A2 New pyridin-3-amine derivatives |
| 08/30/2007 | WO2007080081A3 Process for the preparation of unsymmetric bis(imino) compounds |
| 08/30/2007 | US20070203342 Halogenation and oxidation of a 5-carboxyl-3-oxo-1-aryl-substituted-1H-pyrazolidine |
| 08/30/2007 | US20070203217 Substituted stilbenes and their reactions |
| 08/30/2007 | US20070203207 Heteroaromatic glucokinase activators |
| 08/30/2007 | US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol |
| 08/30/2007 | US20070203204 2-Pyridinylcycloalkylbenzamide Derivatives And Their Use As Fungicides |
| 08/30/2007 | US20070203192 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in treating pain, depression and/or anxiety |
| 08/30/2007 | US20070203191 Insecticidal N-substituted (6-haloalkylpyridin-3-yl)alkyl sulfoximines |
| 08/30/2007 | US20070203131 Bis-aryl sulfonamides |
| 08/30/2007 | US20070203129 2-Pyridone Derivatives As Neutrophil Elastase Inhibitors And Their Use |
| 08/30/2007 | US20070202600 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 08/30/2007 | US20070202598 New transfection reagents |
| 08/30/2007 | US20070202160 Solid-state form of celecoxib having enhanced bioavailability |
| 08/30/2007 | CA2643670A1 Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer |
| 08/30/2007 | CA2643272A1 Gent for treating or preventing digestive ulcer |
| 08/30/2007 | CA2637620A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors |
| 08/29/2007 | EP1824957A2 Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1 |
| 08/29/2007 | EP1824836A2 2-alkyl-cycloalk(en)yl-carboxamides |
| 08/29/2007 | EP1824829A1 3-substituted pyridine derivatives as h3 antagonists |
| 08/29/2007 | EP1824828A2 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
| 08/29/2007 | EP1824827A1 Method for producing onium salts comprising alkyl anions or aryl sulfonate anions or alkyl anions or aryl carboxylate anions having a low halide content |
| 08/29/2007 | EP1824826A1 Aryl sulfonic pyridoxines as antiplatelet agents |
| 08/29/2007 | EP1824825A1 Substituted pyridoxines as anti-platelet agents |
| 08/29/2007 | EP1824821A2 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
| 08/29/2007 | EP1824817A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 08/29/2007 | EP1643998B1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 08/29/2007 | EP1489070B1 Process for production of optically active compounds |
| 08/29/2007 | EP1024814B1 Use of antifungal agents for the topical treatment of fungus-induced mucositis |
| 08/29/2007 | CN101024627A Nitrogen-containing aromatic derivatives |
| 08/28/2007 | US7262318 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 08/28/2007 | US7262211 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for |
| 08/28/2007 | US7262210 Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls |
| 08/28/2007 | US7262209 Carbonyloxy-cyanomethyl compounds as antiparasitic agents |
| 08/28/2007 | US7262208 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 08/28/2007 | US7262196 Tri(cyclo) substituted amide glucokinase activator compounds |
| 08/28/2007 | US7261954 Organo-transition metallic complex having a coordinating carbon such as bis(2-(4,6-difluorophenyl)pyridyl-N,C2 ')iridium(III) picolinate and gallium(III)tris[2-(((pyrrole-2-yl)methylidene)amino)ethyl]amine |
| 08/28/2007 | US7261743 Dicationic compounds for dyeing human keratin fibers, and compositions comprising them |
| 08/28/2007 | CA2230960C Piperazine derivatives and process for the preparation thereof |
| 08/28/2007 | CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 08/28/2007 | CA2160243C 36-derivatives of rifamycins and their use as antimicrobial agents |
| 08/23/2007 | WO2007094135A1 Oligonucleotide derivative and use thereof |
| 08/23/2007 | WO2007093901A1 3 -deazapurine derivatives as tlr7 modulators |
| 08/23/2007 | WO2007093599A1 Pyridin-4 -ylmethylamides for combating pests |
| 08/23/2007 | WO2007093542A1 Pyridine-2-carboxamide derivatives |
| 08/23/2007 | WO2007093530A1 Thioamide compounds for combating animal pest |
| 08/23/2007 | WO2007079010A3 Carbonates of fenicol antibiotics |
| 08/23/2007 | WO2007054558A3 Resorcine derivatives and their use as pesticides |
| 08/23/2007 | WO2007034312A3 Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4) |
| 08/23/2007 | US20070197660 Compounds for modulating cell proliferation |
| 08/23/2007 | US20070197641 Androgen modulators |
| 08/23/2007 | US20070197597 Process for the preparation of tryptase inhibitors |
| 08/23/2007 | US20070197522 Dpp-iv inhibitors |
| 08/23/2007 | US20070197499 Pharmaceutical compounds |
| 08/23/2007 | US20070197495 Anti-parasitic compounds and methods of their use |
| 08/23/2007 | US20070196406 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms |
| 08/23/2007 | US20070194698 Charge transport compositions and electronic devices made with such compositions |
| 08/23/2007 | US20070194468 Method of preparing organomagnesium compounds |
| 08/23/2007 | CA2641133A1 Pyridin-4 -ylmethylamides for combating pests |
| 08/23/2007 | CA2640672A1 3 -deazapurine derivatives as tlr7 modulators |
| 08/23/2007 | CA2640582A1 Pyridine-2-, pyrimidine-2-carboxamide derivatives |
| 08/23/2007 | CA2639911A1 Insecticidal n-substituted (6-haloalkylpyridin-3-yl)alkyl sulfoximines |
| 08/22/2007 | EP1820795A1 Novel anthranilic acid derivative or salt thereof |
| 08/22/2007 | EP1819693A1 Antithrombotic diamides |
| 08/22/2007 | EP1819691A2 Biaryloxymethylarene carboxylic acids |
| 08/22/2007 | EP1819685A1 Substituted oxyguanidines |
| 08/22/2007 | EP1819675A1 5-amino-4-hydroxy-2-isopropyl-7-ý4-methoxy-3-(3-methoxypropxy)benzyl¨-8-methylnonanamides |
| 08/22/2007 | EP1819669A2 Novel inhibitors of histone deacetylase for the treatment of disease |
| 08/22/2007 | EP1819667A1 Sulfonamide compounds as cysteine protease inhibitors |
| 08/22/2007 | EP1572670B1 5-substituted-pyrazine or -pyridine glucokinase activators |
| 08/22/2007 | EP1136470B1 Process for the preparation of a piperazine derivative |
| 08/22/2007 | CN1333621C Phenyl pyridine-iridium metal complex compounds for organic electroluminescent device, and organic electroluminescent device using the compounds |
| 08/22/2007 | CN1332959C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 08/22/2007 | CN1332949C Olefine oligomerization catalyst, and its preparation method and use |
| 08/22/2007 | CN1332942C Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists |
| 08/22/2007 | CN1332939C Novel compounds inhibiting factor Xa activity |
| 08/22/2007 | CN1332921C Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 08/22/2007 | CN101023069A 苯甲酰基取代的丝氨酸酰胺 Benzoyl substituted serine amide |
| 08/22/2007 | CN101023063A Azine-carboxamides as anti-cancer agent |
| 08/22/2007 | CN101023056A Levodopa prodrugs, and compositions and uses thereof |
| 08/22/2007 | CN101022810A Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 08/22/2007 | CN101020677A Cyanoacrylate compounds and their application in pesticide |
| 08/22/2007 | CN101020657A Prepn process of 3-trifluoromethyl-2-pyridyl sulfamide |
| 08/22/2007 | CN101020656A Synthesis process of trichloro pyridyl sodium alcoholate |
| 08/21/2007 | US7259178 Containing an oxazole ring, e.g., 1,1,1,3,3,3-Hexafluoro-2-{4-[[5-methyl-2-(3-trifluoromethyl-phenyl)-oxazol-4-ylmethyl]-(2,2,2-trifluoro-ethyl)-amino]-phenyl}-propan-2-ol; the compounds bind to and selectively activate LXR alpha and LXR beta; used to treat diseases such as atherosclerosis and diabetes |